======= MYCN ======= == Gene Information == * **Official Symbol**: MYCN * **Official Name**: MYCN proto-oncogene, bHLH transcription factor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4613|4613]] * **UniProt**: [[https://www.uniprot.org/uniprot/P04198|P04198]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MYCN&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MYCN|Open PubMed]] * **OMIM**: [[https://omim.org/entry/164840|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]. * **UniProt Summary**: Positively regulates the transcription of MYCNOS in neuroblastoma cells. {ECO:0000269|PubMed:24391509}. |Myc N| |HLH| |positive regulation of production of miRNAs involved in gene silencing by miRNA| |regulation of production of miRNAs involved in gene silencing by miRNA| |regulation of production of small RNA involved in gene silencing by RNA| |positive regulation of gene silencing by miRNA| |positive regulation of posttranscriptional gene silencing| |regulation of gene silencing by miRNA| |regulation of gene silencing by RNA| |regulation of posttranscriptional gene silencing| |kinase binding| |chromatin| |regulation of gene silencing| |protein dimerization activity| |DNA-binding transcription activator activity, RNA polymerase II-specific| |RNA polymerase II proximal promoter sequence-specific DNA binding| |DNA-binding transcription factor activity| |nucleolus| |positive regulation of transcription by RNA polymerase II| |DNA binding| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 9/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|3/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11689 * **Expression level (log2 read counts)**: -1.6 {{:chemogenomics:nalm6 dist.png?nolink |}}